The clinical effect of low-dose ropivacaine combined with sufentanil for subarachnoid anesthesia in cesarean section
剖宫产行小剂量罗哌卡因复合舒芬太尼蛛网膜下腔麻醉的临床效果

摘要

目的 分析小剂量罗哌卡因与舒芬太尼蛛网膜下腔麻醉用于剖宫产中所起到的作用。方法 随机均分2022年6月-2024年6月本院接诊剖宫产产妇（n=68）。试验组采取小剂量罗哌卡因和舒芬太尼蛛网膜下腔麻醉，对照组行小剂量罗哌卡因蛛网膜下腔麻醉。对比麻醉起效时间等指标。结果 关于麻醉起效时间：试验组只有（2.31±0.41）min，对照组长达（4.09±0.72）min，P＜0.05。麻醉优良率：试验组100.0%，对照组76.47%，P＜0.05。产后VAS评分：试验组只有（4.25±1.03）分，对照组高达（7.31±1.42）分，P＜0.05。不良反应：试验组低于对照组（P＜0.05）。结论 剖宫产产妇用小剂量罗哌卡因与舒芬太尼蛛网膜下腔麻醉，效果显著，不良反应也更少，麻醉起效时间更短，产后疼痛感更轻。

Abstract

Objective To analyze the role of low-dose ropivacaine and sufentanil in subarachnoid anesthesia during cesarean section.
Methods Randomly and equally divide the parturients who underwent cesarean section admitted to our hospital from June 2022 to June 2024 (n=68). The experimental group received subarachnoid anesthesia with low-dose ropivacaine and sufentanil, while the control group received subarachnoid anesthesia with low-dose ropivacaine. Compare indicators such as the onset time of anesthesia.
Results Regarding the onset time of anesthesia: The experimental group was only (2.31±0.41) min, while the control group was as long as (4.09±0.72) min, P < 0.05. The excellent and good rate of anesthesia: 100.0% in the experimental group and 76.47% in the control group, P < 0.05. Postpartum VAS score: The experimental group was only (4.25±1.03) points, while the control group was as high as (7.31±1.42) points, P < 0.05. Adverse reactions: The experimental group was lower than the control group (P < 0.05).
Conclusion   Subarachnoid anesthesia with low-dose ropivacaine and sufentanil for parturients undergoing cesarean section has a significant effect, with fewer adverse reactions, shorter onset time of anesthesia, and milder postpartum pain.